Table 5.
Summary of evaluations of alternative cross-linking orientation biases
| Orientation restriction | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dynein | P | P | P | P | I | I | I | I | P | P | P | P | I | I | I | I | |
| HSET | P | P | P | P | P | P | P | P | I | I | I | I | I | I | I | I | |
| MEB | P | P | I | I | P | P | I | I | P | P | I | I | P | P | I | I | |
| Eg5
|
P
|
I
|
P
|
I
|
P
|
I
|
P
|
I
|
P
|
I
|
P
|
I
|
P
|
I
|
P
|
I
|
|
| dhme | - | - | - | + | - | + | + | + | - | + | + | + | + | + | + | + | |
| Simulation cases | dhm | + | + | + | + | + | + | - | - | - | - | - | - | - | - | - | - |
| dm | - | - | + | + | - | - | + | + | - | - | + | + | - | - | + | + | |
| hm | - | - | + | + | - | - | + | + | - | - | + | + | - | - | + | + | |
| dh | + | + | + | + | - | - | - | - | - | - | - | - | - | - | - | - | |
D, dynein; E, Eg5; H, HSET; I, indiscriminate; M, minus-end cross-linking; P, parallel.
+, simulation outcome is not significantly different from combinatorial immunodepletion result (p > 0.05).
-, simulation outcome is significantly different from combinatorial immunodepletion result (p < 0.05).